Immune Profiling in Patients with High-Risk Smoldering Myeloma
Demographics (2)
- COLLECTION_AGE - Subject's age at time of sample collection (phv00492141.v1.p1)
- SEX - Sex (phv00492127.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for Smoldering Multiple Myeloma (SMM) (phv00508636.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00492131.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte type (phv00492138.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00492137.v1.p1)
- COMMENT1 - Library Type (phv00508637.v1.p1)
- COMMENT2 - 10x Kit version (phv00508638.v1.p1)
- CONSENT - Type of consent (phv00492126.v1.p1)
- HISTOLOGICAL_TYPE - Histological type (phv00492140.v1.p1)
- IS_TUMOR - Tumor status (phv00492139.v1.p1)
- PD_RT_IND - Index of progression requiring treatment events (phv00492132.v1.p1)
- PD_RT_TIME - Time in months from date of trial registration to progression requiring treatment or death (phv00492134.v1.p1)
- SAMPLE_ID - Sample ID (phv00492136.v1.p1)
- SAMPLE_ID - Sample ID (phv00492129.v1.p1)
- SOURCE_SUBJECT_ID - Source_Subject_ID (phv00529064.v1.p1)
- SUBJECT_ID - Subject ID (phv00492125.v1.p1)
- SUBJECT_ID - Subject ID (phv00492130.v1.p1)
- SUBJECT_ID - Subject ID (phv00492128.v1.p1)
- SUBJECT_SOURCE - Subject_Source (phv00529063.v1.p1)
- TIMEPOINT - Timepoint at time of collection (phv00492142.v1.p1)
- TUMOR_STAGE - Stage of disease (phv00492143.v1.p1)